Global Neuromyelitis Optica Drug Market Research Report 2016

December 2016 | 112 pages | ID: G9C49CF9F24EN
QYResearch

Abstracts

Notes:

Production, means the output of Neuromyelitis Optica Drug

Revenue, means the sales value of Neuromyelitis Optica Drug

This report studies Neuromyelitis Optica Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Fresenius
• TEVA
• Sandoz
• Intas
• Gyjtrs
• Nang Kuang
• Tianjin Kingyork
• Baxter
• CSL
• Grifols
• Octapharma
• CBOP

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Neuromyelitis Optica Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Glucocorticoids
• Immunoglobulin
• Other

Split by application, this report focuses on consumption, market share and growth rate of Neuromyelitis Optica Drug in each application, can be divided into

• Acute attack
• Remission prophylactic treatment

Contents

Global Neuromyelitis Optica Drug Market Research Report 2016

1 NEUROMYELITIS OPTICA DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Neuromyelitis Optica Drug
1.2 Neuromyelitis Optica Drug Segment by Type
  1.2.1 Global Production Market Share of Neuromyelitis Optica Drug by Type in 2015
  1.2.2 Glucocorticoids
  1.2.3 Immunoglobulin
  1.2.4 Other
1.3 Neuromyelitis Optica Drug Segment by Application
  1.3.1 Neuromyelitis Optica Drug Consumption Market Share by Application in 2015
  1.3.2 Acute attack
  1.3.3 Remission prophylactic treatment
1.4 Neuromyelitis Optica Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Neuromyelitis Optica Drug (2011-2021)

2 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Neuromyelitis Optica Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Neuromyelitis Optica Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Neuromyelitis Optica Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Neuromyelitis Optica Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Neuromyelitis Optica Drug Market Competitive Situation and Trends
  2.5.1 Neuromyelitis Optica Drug Market Concentration Rate
  2.5.2 Neuromyelitis Optica Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NEUROMYELITIS OPTICA DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Neuromyelitis Optica Drug Production and Market Share by Region (2011-2016)
3.2 Global Neuromyelitis Optica Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NEUROMYELITIS OPTICA DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Neuromyelitis Optica Drug Consumption by Regions (2011-2016)
4.2 North America Neuromyelitis Optica Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Neuromyelitis Optica Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Neuromyelitis Optica Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Neuromyelitis Optica Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Neuromyelitis Optica Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Neuromyelitis Optica Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL NEUROMYELITIS OPTICA DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Neuromyelitis Optica Drug Production and Market Share by Type (2011-2016)
5.2 Global Neuromyelitis Optica Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Neuromyelitis Optica Drug Price by Type (2011-2016)
5.4 Global Neuromyelitis Optica Drug Production Growth by Type (2011-2016)

6 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Neuromyelitis Optica Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Neuromyelitis Optica Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NEUROMYELITIS OPTICA DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Fresenius
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Fresenius Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 TEVA
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 TEVA Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Sandoz
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Sandoz Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Intas
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Intas Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Gyjtrs
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Gyjtrs Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Nang Kuang
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Nang Kuang Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Tianjin Kingyork
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Baxter
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Baxter Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 CSL
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Neuromyelitis Optica Drug Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 CSL Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Grifols
7.12 Octapharma
7.13 CBOP

8 NEUROMYELITIS OPTICA DRUG MANUFACTURING COST ANALYSIS

8.1 Neuromyelitis Optica Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neuromyelitis Optica Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neuromyelitis Optica Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neuromyelitis Optica Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEUROMYELITIS OPTICA DRUG MARKET FORECAST (2016-2021)

12.1 Global Neuromyelitis Optica Drug Production, Revenue Forecast (2016-2021)
12.2 Global Neuromyelitis Optica Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Neuromyelitis Optica Drug Production Forecast by Type (2016-2021)
12.4 Global Neuromyelitis Optica Drug Consumption Forecast by Application (2016-2021)
12.5 Neuromyelitis Optica Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neuromyelitis Optica Drug
Figure Global Production Market Share of Neuromyelitis Optica Drug by Type in 2015
Figure Product Picture of Glucocorticoids
Table Major Manufacturers of Glucocorticoids
Figure Product Picture of Immunoglobulin
Table Major Manufacturers of Immunoglobulin
Figure Product Picture of Other
Table Major Manufacturers of Other
Table Neuromyelitis Optica Drug Consumption Market Share by Application in 2015
Figure Acute attack Examples
Figure Remission prophylactic treatment Examples
Figure North America Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Neuromyelitis Optica Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Neuromyelitis Optica Drug Production of Key Manufacturers (2015 and 2016)
Table Global Neuromyelitis Optica Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Neuromyelitis Optica Drug Production Share by Manufacturers
Figure 2016 Neuromyelitis Optica Drug Production Share by Manufacturers
Table Global Neuromyelitis Optica Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Neuromyelitis Optica Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Neuromyelitis Optica Drug Revenue Share by Manufacturers
Table 2016 Global Neuromyelitis Optica Drug Revenue Share by Manufacturers
Table Global Market Neuromyelitis Optica Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Neuromyelitis Optica Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Neuromyelitis Optica Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Neuromyelitis Optica Drug Product Type
Figure Neuromyelitis Optica Drug Market Share of Top 3 Manufacturers
Figure Neuromyelitis Optica Drug Market Share of Top 5 Manufacturers
Table Global Neuromyelitis Optica Drug Production by Regions (2011-2016)
Figure Global Neuromyelitis Optica Drug Production and Market Share by Regions (2011-2016)
Figure Global Neuromyelitis Optica Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Neuromyelitis Optica Drug Production Market Share by Regions
Table Global Neuromyelitis Optica Drug Revenue by Regions (2011-2016)
Table Global Neuromyelitis Optica Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Neuromyelitis Optica Drug Revenue Market Share by Regions
Table Global Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Neuromyelitis Optica Drug Consumption Market by Regions (2011-2016)
Table Global Neuromyelitis Optica Drug Consumption Market Share by Regions (2011-2016)
Figure Global Neuromyelitis Optica Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Neuromyelitis Optica Drug Consumption Market Share by Regions
Table North America Neuromyelitis Optica Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Neuromyelitis Optica Drug Production, Consumption, Import & Export (2011-2016)
Table China Neuromyelitis Optica Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Neuromyelitis Optica Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Neuromyelitis Optica Drug Production, Consumption, Import & Export (2011-2016)
Table India Neuromyelitis Optica Drug Production, Consumption, Import & Export (2011-2016)
Table Global Neuromyelitis Optica Drug Production by Type (2011-2016)
Table Global Neuromyelitis Optica Drug Production Share by Type (2011-2016)
Figure Production Market Share of Neuromyelitis Optica Drug by Type (2011-2016)
Figure 2015 Production Market Share of Neuromyelitis Optica Drug by Type
Table Global Neuromyelitis Optica Drug Revenue by Type (2011-2016)
Table Global Neuromyelitis Optica Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Neuromyelitis Optica Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Neuromyelitis Optica Drug by Type
Table Global Neuromyelitis Optica Drug Price by Type (2011-2016)
Figure Global Neuromyelitis Optica Drug Production Growth by Type (2011-2016)
Table Global Neuromyelitis Optica Drug Consumption by Application (2011-2016)
Table Global Neuromyelitis Optica Drug Consumption Market Share by Application (2011-2016)
Figure Global Neuromyelitis Optica Drug Consumption Market Share by Application in 2015
Table Global Neuromyelitis Optica Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Neuromyelitis Optica Drug Consumption Growth Rate by Application (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Neuromyelitis Optica Drug Market Share (2011-2016)
Table Fresenius Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fresenius Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Fresenius Neuromyelitis Optica Drug Market Share (2011-2016)
Table TEVA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TEVA Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure TEVA Neuromyelitis Optica Drug Market Share (2011-2016)
Table Sandoz Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sandoz Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Neuromyelitis Optica Drug Market Share (2011-2016)
Table Intas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intas Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Intas Neuromyelitis Optica Drug Market Share (2011-2016)
Table Gyjtrs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gyjtrs Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Gyjtrs Neuromyelitis Optica Drug Market Share (2011-2016)
Table Nang Kuang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nang Kuang Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Nang Kuang Neuromyelitis Optica Drug Market Share (2011-2016)
Table Tianjin Kingyork Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tianjin Kingyork Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Tianjin Kingyork Neuromyelitis Optica Drug Market Share (2011-2016)
Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Neuromyelitis Optica Drug Market Share (2011-2016)
Table CSL Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Neuromyelitis Optica Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Neuromyelitis Optica Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromyelitis Optica Drug
Figure Manufacturing Process Analysis of Neuromyelitis Optica Drug
Figure Neuromyelitis Optica Drug Industrial Chain Analysis
Table Raw Materials Sources of Neuromyelitis Optica Drug Major Manufacturers in 2015
Table Major Buyers of Neuromyelitis Optica Drug
Table Distributors/Traders List
Figure Global Neuromyelitis Optica Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Neuromyelitis Optica Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Neuromyelitis Optica Drug Production Forecast by Regions (2016-2021)
Table Global Neuromyelitis Optica Drug Consumption Forecast by Regions (2016-2021)
Table Global Neuromyelitis Optica Drug Production Forecast by Type (2016-2021)
Table Global Neuromyelitis Optica Drug Consumption Forecast by Application (2016-2021)